首页> 外国专利> METHOD FOR PRODUCTION OF HYDROCHLORIDE 1(10) BETA-EPOXY-13-DIMETHYLAMINO-5,7α,6,11β(H)-GUAIA-3(4)-EN-6,12-OLIDE, LYOPHILIZED ANTITUMOR PREPARATION 'ARGLABIN'

METHOD FOR PRODUCTION OF HYDROCHLORIDE 1(10) BETA-EPOXY-13-DIMETHYLAMINO-5,7α,6,11β(H)-GUAIA-3(4)-EN-6,12-OLIDE, LYOPHILIZED ANTITUMOR PREPARATION 'ARGLABIN'

机译:制备盐酸盐1(10)β-环氧-13-二甲基氨基-5,7α,6,11β(H)-GUAIA-3(4)-EN-6,12-内酯的方法是将磷脂酰化的抗静电剂制备成“阿格布林”

摘要

The invention relates to a method for production of new medicinal preparations from the natural raw material, namely antitumor preparation "Arglabin" and can be used for chemotherapy of malignant tumors and dilating of range of immunomodulating preparations. The aim of the invention is the development of a method for production of an antitumor preparation on the basis of natural sesquiterpene lactone, excluding the use of toxic reagents and providing significant reduction of production process time. Said technical result is achieved by producing hydrohloride 1(10)β-epoxy-13-dimethylamino-5,7α,6,11β(H)-guaia-3(4)-en-6,12-olide hydrochloride, the lyophilized, antitumor preparation having radio-sensitizing and immunomodulating activities. The method includes extraction of the natural raw material - endemic plant Artemisia glabella Kar. et Kir., separation of obtained resin on individual components and extraction of technical arglabin, dimethylaminoarglabin hydrochloride is synthesized therefrom, with the subsequent purification, drying and lyophilization thereof. The extraction is carried out with the use of fluid carbon dioxide as extragent at pressure 150±2-105 Pa and at temperature 60°C±0.5, the separation of resin on individual components is carried out by the method of preparative fluid chromatography, applying reversed phase C18. Technical arglabin is dissolved in acetonitrile at the weight ratio 1:10 with dimethylammonium dimethylcarbamat in the molar ratio 1:1.62 at the synthesis of dimethylaminoarglabin hydrochloride.
机译:本发明涉及从天然原料生产新的药物制剂的方法,即抗肿瘤制剂“ Arglabin”,可用于恶性肿瘤的化学疗法和扩大免疫调节制剂的范围。发明内容本发明的目的是开发一种基于天然倍半萜烯内酯的抗肿瘤制剂的生产方法,该方法不使用有毒试剂并显着减少生产过程时间。通过生产冷冻干燥的氢卤化物1(10)β-环氧-13-二甲基氨基-5,7α,6,11β(H)-guaia-3(4)-en-6,12-乙交酯盐酸盐来实现上述技术结果,具有放射增敏和免疫调节活性的抗肿瘤制剂。该方法包括提取天然原料-特有植物蒿(Artemisia glabella Kar)。等人,分离得到的树脂在各个组分上的成分,并从中合成工业用精醇,即二甲基氨基精氨酸盐酸盐,随后对其进行纯化,干燥和冻干。萃取是在压力为150±2-10 5 Pa且温度为60°C±0.5的条件下使用液态二氧化碳作为萃取剂进行的,通过以下步骤进行树脂分离:制备液相色谱法,应用反相C18。在合成二甲基氨基精氨酯盐酸盐时,将工业精氨脂与二甲基铵二甲氨基甲酸铵以1:1.62的摩尔比,以1:10的重量比溶解在乙腈中。

著录项

  • 公开/公告号EA015557B1

    专利类型

  • 公开/公告日2011-08-30

    原文格式PDF

  • 申请/专利权人 SERGAZY MYNZHASAROVICH;

    申请/专利号EA20090000353

  • 发明设计人 SERGAZY MYNZHASAROVICH;

    申请日2006-12-21

  • 分类号C07D493/10;

  • 国家 EA

  • 入库时间 2022-08-21 18:06:38

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号